Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer
Authors:
Open Access
- 1 November 2005
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 18 (11) , 1482-1489
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Expression of EGFR and Cerb-B2 as prognostic factors in cancer of the tongueOral Oncology, 2004
- Co‐localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinomaThe Journal of Pathology, 2001
- The Expression of Cyclins D1 and E in Predicting Short-Term Survival in Squamous Cell Carcinoma of the LungLaboratory Investigation, 2000
- Cancer Cell CyclesScience, 1996
- p53 Expression: Predicting Recurrence and Second Primary Tumors in Head and Neck Squamous Cell CarcinomaJNCI: Journal of the National Cancer Institute, 1996
- The retinoblastoma protein and cell cycle controlCell, 1995
- Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts.Genes & Development, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- The p53 tumour suppressor geneNature, 1991